Clinical Trial TitleNRG-BN003: Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
National Clinical Trial Number:NCT03180268
Clinical Trial Protocol Description:
This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have a newly diagnosed unifocal intracranial meningioma, gross totally resected, and histologically confirmed as WHO grade II based upon pathology findings at the enrolling institution.
- Are registered within 180 days of the initial surgery.
- Are 18 years of age or older.
- Have not received previous radiotherapy to the scalp, cranium, brain, or skull base.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.